Table 4. Relative integrals (%)1 from selected plasma metabolites in piglets of all groups.
Metabolites | Relative integrals (%)1 | SEM | P-value | ||||
NC | DON | GLU | DG | ||||
HDL(δ0.83) | CPMG | 1.971b | 1.751c | 2.270a | 2.007ab | 0.091 | <0.01 |
Standard 1D | 1.926a | 1.814b | 1.948a | 1.848b | 0.014 | <0.01 | |
LDL (δ0.84) | CPMG | 1.010b | 1.266a | 0.964b | 1.261a | 0.036 | <0.01 |
Standard 1D | 1.001b | 1.062a | 0.992b | 1.051a | 0.008 | <0.01 | |
Alanine (δ1.48) | CPMG | 1.033b | 1.237a | 0.980b | 1.016b | 0.026 | <0.01 |
Standard 1D | 1.013b | 1.040a | 1.003bc | 0.993c | 0.005 | <0.01 | |
Arginine (δ1.63) | CPMG | 0.502b | 0.658a | 0.499b | 0.610ab | 0.022 | <0.01 |
Standard 1D | 1.249b | 1.314a | 1.248b | 1.304a | 0.009 | <0.01 | |
Acetate (δ1.92) | CPMG | 0.172b | 0.218a | 0.194b | 0.173b | 0.005 | <0.01 |
Standard 1D | 0.310b | 0.318a | 0.320ab | 0.318ab | 0.005 | 0.168 | |
Proline(δ2.00) | CPMG | 1.204a | 0.987b | 1.185a | 1.083ab | 0.024 | <0.01 |
Standard 1D | 1.478a | 1.408c | 1.486a | 1.450b | 0.008 | <0.01 | |
Glycoprotein (δ2.05) | CPMG | 2.190b | 2.766a | 2.254b | 2.630a | 0.063 | <0.01 |
Standard 1D | 1.461c | 1.593a | 1.460c | 1.513b | 0.014 | <0.01 | |
Citrate (δ2.52) | CPMG | 0.196a | 0.166b | 0.187a | 0.197a | 0.004 | <0.01 |
Standard 1D | 0.463a | 0.451b | 0.464a | 4.681a | 0.002 | <0.01 | |
TMAO (δ3.26) | CPMG | 0.575b | 0.811a | 0.549b | 0.613b | 0.029 | <0.01 |
Standard 1D | 0.169b | 0.227a | 0.184b | 0.183b | 0.006 | <0.01 | |
Glycine (δ3.56) | CPMG | 1.179b | 1.439a | 1.237b | 1.242b | 0.028 | <0.01 |
Standard 1D | 0.343b | 0.380a | 0.347b | 0.337b | 0.005 | <0.01 | |
Lactate (δ4.11) | CPMG | 2.462bc | 3.817a | 2.316c | 3.154ab | 0.158 | <0.01 |
Standard 1D | 1.289b | 1.549a | 1.234b | 1.260b | 0.034 | <0.01 | |
Unsaturated lipids (δ5.31) | CPMG | 0.706a | 0.576b | 0.712a | 0.678ab | 0.018 | 0.014 |
Standard 1D | 0.757a | 0.640c | 0.781a | 0.679b | 0.014 | <0.01 | |
Urea (δ5.78) | CPMG | 0.178b | 0.271a | 0.178b | 0.244a | 0.010 | <0.01 |
Standard 1D | 0.165c | 0.212a | 0.179b | 0.204a | 0.005 | <0.01 | |
Fumarate (δ6.52) | CPMG | 0.0061a | 0.0033b | 0.0061a | 0.0057a | 0.00003 | <0.01 |
Standard 1D | 0.028a | 0.026b | 0.028a | 0.028a | 0.000 | 0.016 | |
Glutamate/ Creatinine | CPMG | 3.300b | 4.152a | 3.352b | 3.435b | 0.086 | <0.01 |
Standard 1D | 3.265 | 3.253 | 3.252 | 3.248 | 0.023 | 0.995 |
Data are presented as means ± SEM, n = 5 for treatments, with a-c used to indicate statistically significant difference (P<0.05, one way ANOVA method). Normalized integral of metabolites in spectrum (normalized to 100, chemical shift region over the ranges of δ 0.5–4.55 and δ 5.13–8.5.
Dietary treatments were NC, an uncontaminated basal diet, DON, the basal contaminated with 4 mg/kg deoxynivalenol, GLU, uncontaminated basal diet with 2% glutamic acid supplementation, and DG, deoxynivalenol-contaminated (4 mg/kg) basal diet with 2% glutamic acid supplementation (n = 5).